BAMF
PACB icon

BI Asset Management Fondsmaeglerselskab’s Pacific Biosciences PACB Stock Holding History

BI Asset Management Fondsmaeglerselskab’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-15,996
Closed -$22K – 658
2024
Q2 		$22K Buy
15,996
+5,908
+59% +$11.9K ﹤0.01% 630
2024
Q1 		$38K Buy
+10,088
New +$59.1K ﹤0.01% 710
2023
Q4 		– Sell
-102,765
Closed -$858K – 770
2023
Q3 		$858K Buy
+102,765
New +$1.17M 0.02% 403

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $7.59B AUM 23.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

BI Asset Management Fondsmaeglerselskab's PACB Position: Q3 2024 in Review

BI Asset Management Fondsmaeglerselskab sold out of Pacific Biosciences (PACB) in Q3 2024, closing a stake of 15,996 shares — an estimated $22K sold.

BI Asset Management Fondsmaeglerselskab first reported a position in PACB in Q3 2023 and held it in 3 quarters. The position peaked at $858K in Q3 2023. 226 funds tracked by Wall St. Rank hold PACB as of Q3 2024.

  • BI Asset Management Fondsmaeglerselskab reported no remaining Pacific Biosciences position as of Q3 2024 after selling out during the quarter.
  • BI Asset Management Fondsmaeglerselskab sold 15,996 Pacific Biosciences shares in Q3 2024, an estimated $22K.
  • BI Asset Management Fondsmaeglerselskab first reported a position in Pacific Biosciences in Q3 2023 and held it in 3 quarters.
  • BI Asset Management Fondsmaeglerselskab's Pacific Biosciences position peaked at $858K in Q3 2023.
  • 226 funds tracked by Wall St. Rank held Pacific Biosciences as of Q3 2024.

Based on BI Asset Management Fondsmaeglerselskab's 13F filing for Q3 2024, filed 13 Nov 2024.